| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 03/14/1996 | WO1996007435A1 Process for preparing macrocyclic chelating agents and formation of chelates and conjugates thereof |
| 03/14/1996 | WO1996007430A1 Therapeutic treatment of clostridium difficile associated diseases |
| 03/14/1996 | WO1996007321A1 Methods for modulating protein function in cells using intracellular antibody homologues |
| 03/14/1996 | WO1996006168A3 Retinoblastoma protein-interacting zinc finger proteins |
| 03/14/1996 | WO1996004378A3 Chimeric proteins and muteins of tissue factor pathway inhibitors tfpi and tfpi-2 |
| 03/14/1996 | WO1995035111A3 USE OF βGalNac(1-4)βGal CONJUGATES TO TREAT CANDIDA INFECTION |
| 03/14/1996 | CA2199609A1 Interleukin-1 type 3 receptors |
| 03/14/1996 | CA2199499A1 Screening method for periodontal disease |
| 03/14/1996 | CA2199387A1 Process for preparing macrocyclic chelating agents and formation of chelates and conjugates thereof |
| 03/14/1996 | CA2198935A1 Monoclonal recombinant anti-rhesus d (d7c2) antibody |
| 03/14/1996 | CA2198707A1 Predictive test for hepatitis-b resistance |
| 03/14/1996 | CA2197714A1 Therapeutic treatment of clostridium difficile associated diseases |
| 03/13/1996 | EP0701000A2 Recombinant thermostable DNA polymerase from archaebacteria |
| 03/13/1996 | EP0700999A2 Expression systems utilizing autolyzing fusion proteins and a novel reducing polypeptide |
| 03/13/1996 | EP0700994A1 Anti-igf-i monoclonal antibody |
| 03/13/1996 | EP0700993A1 Anti-thymosin alpha 1 monoclonal antibody-producing hybridoma |
| 03/13/1996 | EP0700930A1 Tumor affinity peptide, and radioactive diagnostic agent and radioactive therapeutic agent containing the peptide |
| 03/13/1996 | EP0700446A1 Antibodies specific for dcc gene product |
| 03/13/1996 | EP0700444A1 Immunotoxins comprising gelonin and an antibody |
| 03/13/1996 | EP0700441A1 Multiple sclerosis virus |
| 03/13/1996 | EP0700440A1 Regulator of contact-mediated hemolysin |
| 03/13/1996 | EP0700439A1 Lymphocyte chemoattractant factor and uses thereof |
| 03/13/1996 | EP0700438A1 Opioid receptors: compositions and methods |
| 03/13/1996 | EP0700430A1 Methods for selectively stimulating proliferation of t cells |
| 03/13/1996 | EP0700402A1 Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodies |
| 03/13/1996 | EP0700305A1 Monoclonal anti-idiotypic anti-ca125 antibodies and pharmaceutical compositions containing them |
| 03/13/1996 | EP0550691B1 Antibody inductor peptides inhibiting retroviruses of the hiv type and antibodies specific for said peptides |
| 03/13/1996 | EP0528932B1 Acute pancreatitis associated protein and means for the diagnosis of acute pancreatitis |
| 03/13/1996 | EP0491007B1 Structural alterations of the egf receptor gene in human gliomas |
| 03/13/1996 | EP0438497B1 Vasopermeability-enhancing conjugates |
| 03/13/1996 | EP0436598B1 Cell sorting technique and applications thereof |
| 03/13/1996 | EP0436545B1 Therapeutic methods using catalytic antibodies |
| 03/13/1996 | EP0428602B1 Polypeptides and dna encoding same |
| 03/13/1996 | CA2131868A1 Suppression of nephritis-induced protein excretion by anti-il-8 |
| 03/12/1996 | US5498538 Totally synthetic affinity reagents |
| 03/12/1996 | US5498531 Intron-mediated recombinant techniques and reagents |
| 03/12/1996 | US5498499 Peptides and antibodies that inhibit platelet adhesion |
| 03/10/1996 | CA2145905A1 Anti-thymosin .alpha.1 monoclonal antibody-producing hybridoma |
| 03/07/1996 | WO1996007103A1 Methods and test kits for specific and sensitive diagnosing of periodontal diseases |
| 03/07/1996 | WO1996007098A1 Marker for individuals susceptible to alcoholism |
| 03/07/1996 | WO1996006863A1 Agents for inducing apoptosis and applications of said agents in therapy |
| 03/07/1996 | WO1996006862A1 Gabaa receptor epsilon subunit |
| 03/07/1996 | WO1996006860A2 Gradual modification, super-agonists and antagonists of signal-proteins and peptides |
| 03/07/1996 | WO1996006859A1 Trophic factors for central nervous system regeneration |
| 03/07/1996 | WO1996006858A1 (1→3)-β-D-GLUCAN-BINDING PROTEIN, ANTIBODY THAT RECOGNIZES THE PROTEIN, AND USE OF THE PROTEIN AND ANTIBODY |
| 03/07/1996 | WO1996006856A1 Dopamine receptor peptides and anti-peptide antibodies |
| 03/07/1996 | WO1996006642A1 Allogeneic and xenogeneic transplantation |
| 03/07/1996 | WO1996006625A1 Antibody constructs with cdr switched variable regions |
| 03/07/1996 | WO1996006619A1 Polynucleic acids and proteins from a porcine reproductive and respiratory syndrome virus and uses thereof |
| 03/07/1996 | WO1996004385A3 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
| 03/07/1996 | WO1995032291A3 Hepatitis g virus and molecular cloning thereof |
| 03/07/1996 | DE4431297A1 Antibody VFF-18 specific for epitope encoded by exon v6 of CD44 |
| 03/07/1996 | DE19531931A1 Modulatoren des Körpergewichts, korrespondierende Nukleinsäuren und Proteine, und diagnostische und therapeutische Verwendungen derselben Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
| 03/07/1996 | CA2198919A1 Gradual modification, super agonists and antagonists of signs and peptides |
| 03/07/1996 | CA2198863A1 Marker for individuals susceptible to alcoholism |
| 03/07/1996 | CA2198587A1 Trophic factors for central nervous system regeneration |
| 03/07/1996 | CA2197452A1 Methods and test kits for specific and sensitive diagnosing of periodontal diseases |
| 03/06/1996 | EP0699907A2 Diagnostic methods soluble CD8 T cell surface antigen and anti-CD8 antibody |
| 03/06/1996 | EP0699766A1 Therapeutic antibody based fusion proteins with platelet factor-4 |
| 03/06/1996 | EP0699756A1 Novel mutant BR96 antibodies and functional equivalents reactive with human carcinomas |
| 03/06/1996 | EP0699755A2 Method for obtaining modified immunoglobulins with reduced immunogenicity of murine antibody variable domains, compositions containing them |
| 03/06/1996 | EP0699688A2 Chlamydia pneumoniae specific monoclonal antibodies and their diagnostic use |
| 03/06/1996 | EP0699306A1 Assay for cardiac troponin i |
| 03/06/1996 | EP0699305A1 Methods, agents and kits for detection of organophosphorus compounds |
| 03/06/1996 | EP0699237A1 Anti-egfr single-chain fvs and anti-egfr antibodies |
| 03/06/1996 | EP0699236A1 Purified mammalian flt3 ligands and agonists and antagonists thereof |
| 03/06/1996 | EP0699235A1 Animal model for hepatitis virus infection |
| 03/06/1996 | EP0699078A1 A method to prevent side effects and insensitivity to the therapeutic uses of toxins |
| 03/06/1996 | EP0699077A1 Hiv immunogenic complexes |
| 03/06/1996 | EP0476059B1 Methods for enhancing the rate of modification of metastable bonds |
| 03/06/1996 | EP0449955B1 Synthetic hiv-like peptides, their compositions and uses |
| 03/06/1996 | EP0416033B1 Macrocyclic chelates and methods of use thereof |
| 03/06/1996 | EP0395653B1 Synovial phospholipases |
| 03/06/1996 | CN1117974A Method for extracting antibody from yolk |
| 03/06/1996 | CN1117873A Usage of follicle-stimulating hormone |
| 03/05/1996 | USRE35171 Consisting of glutamyl/transferase/gamma-/ and a purified protein having specified molecular weight limits; purification by chromatography |
| 03/05/1996 | US5496934 Nucleic acids encoding a cellulose binding domain |
| 03/05/1996 | US5496925 5(6)-methyl substituted fluorescein derivatives |
| 03/05/1996 | US5496802 Protein; antibody |
| 03/05/1996 | US5496706 Methods and materials for the detection of Staphylococcus aureus |
| 03/05/1996 | US5496705 Monoclonal antibody specific for rat synaptophysin |
| 03/05/1996 | US5496550 Method of reducing the output of Eimeria oocysts from a newborn chick |
| 03/05/1996 | US5496549 Bispecific monoclonal antibodies, thrombolytic agent and method of cell lysis |
| 03/05/1996 | US5496548 Human anti-RH(D) monoclonal antibodies, cell lines and methods of use of antibodies in immunoassays |
| 03/05/1996 | CA2012264C Anti-human sperm antibody and its production and use |
| 03/05/1996 | CA1338122C Tissue factor inhibitor of coagulation |
| 02/29/1996 | WO1996006357A1 Screen for potential therapeutic compounds |
| 02/29/1996 | WO1996006174A1 RECOMBINANT DNase B DERIVED FROM STREPTOCOCCUS PYOGENES |
| 02/29/1996 | WO1996006171A2 New polypetides having a toxic activity against insects of the dipterae family |
| 02/29/1996 | WO1996006169A1 Human chemokine beta-9 |
| 02/29/1996 | WO1996006168A2 Retinoblastoma protein-interacting zinc finger proteins |
| 02/29/1996 | WO1996006167A1 Glutamate receptor |
| 02/29/1996 | WO1996006164A1 Method for isolating mutant cells |
| 02/29/1996 | WO1996006159A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 02/29/1996 | WO1996006116A1 Immunoconjugates comprising tyrosine kinase inhibitors |
| 02/29/1996 | WO1996006115A1 Product and method for detecting internalin |
| 02/29/1996 | WO1996006113A1 New immunocontraceptive peptides |
| 02/29/1996 | WO1996006112A1 Antigenic peptides derived from the g protein of rsv for type- and subtype-specific diagnosis of respiratory syncytial virus (rsv) infection |
| 02/29/1996 | WO1996005860A1 A method of treating a patient with a biologically active compound |
| 02/29/1996 | WO1996005859A1 Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections |